ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Desenlaces materno-fetales en mujeres con diabetes gestacional en un programa control intensivo / Maternal-fetal outcomes in women with gestational diabetes in an intensive control program

Rafael Violante-Ortiz, Norma Lidia Fernández-Ordoñez, Claudio Abel Requena-Rivera, Salvador Sabino Mojarro-Bazán, Tania Alemán-Cabrera

Resumen


Resumen

Introducción: la diabetes mellitus gestacional (DMG) se diagnóstica por primera vez en el embarazo y es la hiper-glucemia materna más frecuente.

Objetivo: conocer los desenlaces fetales y maternos en un programa de control intensivo en mujeres embarazadas con y sin DMG en el Hospital General Regional No. 6 del Instituto Mexicano del Seguro Social (IMSS) en Ciudad Madero, Tamaulipas.

Material y métodos: estudio descriptivo y retrospectivo que incluyó 800 desenlaces de mujeres gestantes entre enero de 2009 y junio de 2020. Se recopilaron datos antropométricos y desenlaces del embarazo. El programa de control intensivo consistió en consultas presenciales de una a cuatro semanas, otorgadas según el grado de control metabólico, en las que se proporcionó consejería nutricional, recomendaciones de actividad física y en algunos casos tratamiento farmacológico.

Resultados: la prevalencia de DMG fue de 36.2%. No hubo diferencias estadísticamente significativas en ambos grupos, a excepción del síndrome de distrés respiratorio, que fue más frecuente en DMG (9.4%, p = 0.06). Las pacientes con DMG tuvieron menor prevalencia de macrosomía (6.1%) a diferencia del grupo control (6.6%). Toda mujer ingresada al programa en el primer trimestre tuvo menores complicaciones fetales y maternas.

Conclusiones: este estudio demuestra la eficacia y eficiencia de implementar un programa de control intensivo en mujeres con DMG, al reducir e igualar los desenlaces maternos y fetales en comparación con un grupo de mujeres sin la enfermedad.

 

Abstract

Background: Gestational diabetes mellitus (GDM) is first diagnosed during pregnancy and it is the most frequent maternal hyperglycemia.

Objective: To know fetal and maternal outcomes in an intensive control program in pregnant women with and without DMG at the Instituto Mexicano del Seguro Social (Mexican Institute for Social Security) Regional General Hospital No. 6, in Ciudad Madero, Tamaulipas.

Material and methods: A descriptive and retrospective study, which included 800 outcomes of pregnant women between January 2009 and June 2020. Anthropometric data and pregnancy outcomes were collected. The intensive control program consisted of face-to-face consultations of 1 to 4 weeks, granted according to the degree of metabolic control, with which it was given nutritional counseling, recommendations for physical activity, and in some cases pharmacological treatment.

Results: The prevalence of GDM was 36.2%. There were no statistically significant differences between the two groups, except for respiratory distress syndrome, which was more common in GDM (9.4%, p = 0.06). Patients with GDM had a lower prevalence of macrosomy (6.1%) compared to the control group (6.6%). All women admitted to the program in the first trimester had fewer fetal and maternal complications.

Conclusions: This study demonstrates the effectiveness and efficiency of implementing an intensive control program in women with GDM, by reducing and equalizing maternal and fetal outcomes compared to a group of women without the disease.


Palabras clave


Diabetes Mellitus Gestacional; Desenlaces; Complicaciones; Macrosomía / Gestational Diabetes Mellitus; Outcomes; Complications; Macrosomy

Texto completo:

PDF

Referencias


 

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-27.

 

Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y, Bancher-Todesca D, Berger A, Repa A, et al. Gestational diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1): 91-102.

 

Hernández-Higareda S, Pérez-Pérez OA, Balderas-Peña LMA, Martínez-Herrera BE, Salcedo-Rocha AL, Ramírez-Conchas RE. Enfermedades metabólicas maternas asociadas a sobrepeso y obesidad pregestacional en mujeres mexicanas que cursan con embarazo de alto riesgo. Cirugia y Cirujanos (English Edition). 2017;85(4).

 

Reyes-Muñoz E, Parra A, Castillo-Mora A, Ortega-González C. Effect of the diagnostic criteria of the international association of diabetes and pregnancy study groups on the prevalence of gestational diabetes mellitus in urban mexican women: A cross-sectional study. Endocrine Practice. 2012;18(2).

 

Encuesta Nacional de Salud y Nutrición 2018 Presentación de resultados.

 

Lende M, Rijhsinghani A. Gestational Diabetes: Overview with Emphasis on Medical Management. Available from: www.mdpi.com/journal/ijerph.

 

Song Z, Cheng Y, Li T, Fan Y, Zhang Q, Cheng H. How do pregnant women’s perceptions of obstetric forceps change according to their demographic background: a cross sectional study. BMC Pregnancy and Childbirth [Internet]. 2021; Available from: https://doi.org/10.1186/s12884-022-04615-0.

 

Giannakou K, Evangelou E, Yiallouros P, Christophi CA, Middleton N, Papatheodorou E, et al. Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies. PLoS ONE. 2019;14(4).

 

Id KG, Evangelou E, Yiallouros P, Christophi CA, Middleton N, Papatheodorou E, et al. Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies. 2019; Available from: https://doi.org/10.1371/ journal.pone.0215372.

 

Phaloprakarn C, Tangjitgamol S. Risk score for predicting primary cesarean delivery in women with gestational diabetes mellitus. BMC Pregnancy and Childbirth. 2020;20(1).

 

Oteng-Ntim E, Varma R, Croker H, Poston L, Doyle P. Life-style interventions for overweight and obese pregnant women to improve pregnancy outcome: Systematic review and meta-analysis. BMC Medicine. 2012;10.

 

Maestro C. GUÍA DE PRÁCTICA CLÍNICA GPC Prevención, diagnóstico y tratamiento DE LA PREECLAMPSIA en segundo y tercer nivel de atención Evidencias y Recomendaciones [Internet]. 2017. Available from: http://www.cenetec.salud. gob.mx/contenidos/gpc/catalogoMaestroGPC.html.

 

Yang Y, le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Network Open. 2021;

 

Chen JS, Roberts CL, Simpson JM, Ford JB. Prevalence of pre-eclampsia, pregnancy hypertension and gestational diabetes in population-based data: Impact of different ascertainment methods on outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2012;52(1).

 

Östlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2004;113(1).

 

Zhuang W, Lv J, Liang Q, Chen W, Zhang S, Sun X. Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures. Experimental and Therapeutic Medicine. 2020;

 

Preciado LML, Domínguez MCP, Morales JLF, Calle KC, Campo MNC, Castro DPC. Perfil clínico de pacientes con diabetes gestacional e incidencia de complicaciones neonatales en un centro de referencia materno-fetal colombiano. Revista chilena de obstetricia y ginecología. 2020;85(3).

 

Forsbach-Sanchez G, Vasquez-Lara J, Hernández-Herrera R, Támez-Pérez HE. Morbilidad neonatal asociada a diabetes gestacional. Revista médica. 2007;

 

Kim MH, Kwak SH, Kim SH, Hong JS, Chung HR, Choi SH, et al. Pregnancy outcomes of women additionally diagnosed as gestational diabetes by the International Association of the Diabetes and Pregnancy Study groups criteria. Diabetes and Metabolism Journal. 2019;43(6).

 

Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. New England Journal of Medicine. 2021;384(10).

 

Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60(4).

 

Agudelo-Espitia V, Parra-Sosa BE, Restrepo-Mesa SL. Factors associated with fetal macrosomía. Revista de Saude Publica. 2019;53.

 

Stogianni A, Lendahls L, Landin-Olsson M, Thunander M. Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Pregnancy and Childbirth. 2019;19(1).

 

Usami T, Yokoyama M, Ueno M, Iwama N, Sagawa N, Kawano R, et al. Comparison of pregnancy outcomes between women with early-onset and late-onset gestational diabetes in a retrospective multi-institutional study in Japan. Journal of Diabetes Investigation. 2020;11(1).

 

Shindo R, Aoki S, Nakanishi S, Misumi T, Miyagi E. Impact of gestational diabetes mellitus diagnosed during the third trimester on pregnancy outcomes: a case-control study. BMC Pregnancy and Childbirth. 2021;21(1).

 


Enlaces refback

  • No hay ningún enlace refback.